• 1
    Scharbo-Dehaan M 1996 Hormone replacement therapy. Nurse Pract 21:113.
  • 2
    Genant HK, Baylink DJ, Gallagher JC 1989 Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161:18421846.
  • 3
    Ravnikar VA 1987 Compliance with hormone therapy. Am J Obstet Gynecol 156:13321334.
  • 4
    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford, SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321333.
  • 5
    Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C 2002 Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334341.
  • 6
    Grodstein F, Manson JE, Stampfer MJ 2001 Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study: A prospective, observational study. Ann Intern Med 135:18.
  • 7
    Alexander KP, Newby LK, Hellkamp AS, Harrington RA, Peterson ED, Kopecky S, Langer A, O'Gara P, O'Connor CM, Daly RN, Califf RM, Khan S, Fuster V 2001 Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol 38:17.
  • 8
    Das UN 2000 Essential fatty acids and osteoporosis. Nutrition 16:386390.
  • 9
    Kruger MC, Horrobin DF 1997 Calcium metabolism, osteoporosis and essential fatty acids: A review. Prog Lipid Res 36:131151.
  • 10
    Watkins BA, Lippman HE, Le Bouteiller L, Li Y, Seifert MF 2001 Bioactive fatty acids: Role in bone biology and bone cell function. Prog Lipid Res 40:125148.
  • 11
    Teegarden D, Lyle RM, Proulx WR, Johnston CC, Weaver CM 1999 Previous milk consumption is associated with greater bone density in young women. Am J Clin Nutr 69:10141017.
  • 12
    Weaver CM, Peacock M, Johnston CC Jr 1999 Adolescent nutrition in the prevention of postmenopausal osteoporosis. J Clin Endocrinol Metab 84:18391843.
  • 13
    Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH 1998 Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 10:385394.
  • 14
    Das UN 1991 Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: Relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular disease. Prostaglandins Leukot Essent Fatty Acids 44:201210.
  • 15
    Li Y, Seifert MF, Ney DM, Grahn M, Grant AL, Allen KG, Watkins BA 1999 Dietary conjugated linoleic acids alter serum IGF-I and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res 14:11531162.
  • 16
    Coetzer H, Claassen N, van Papendorp DH, Kruger MC 1994 Calcium transport by isolated brush border and basolateral membrane vesicles: Role of essential fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 50:257266.
  • 17
    Kris-Etherton PM, Harris WS, Appel LJ 2002 Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:27472757.
  • 18
    Bucher HC, Hengstler P, Schindler C, Meier G 2002 N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials. Am J Med 112:298304.
  • 19
    Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J 2002 Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346:11131118.
  • 20
    Robinson DR, Knoell CT, Urakaze M, Huang R, Taki H, Sugiyama E, Xu LL, Yeh ET, Olesiak W, Guo M, Colvin RB, Auron, PE 1995 Suppression of autoimmune disease by omega-3 fatty acids. Biochem Soc Trans 23:287291.
  • 21
    Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G 1994 Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZBxNZW F1 mice. Lipids 29:561568.
  • 22
    Prickett JD, Robinson DR, Steinberg AD 1981 Dietary enrichment with the PUFA eicosapentaenoic prevents proteinuria and prolongs survival in NZBxNZWF1 mice. J Clin Invest 658:556559.
  • 23
    Fernandes G, Bysani C, Venkatraman JT, Tomar V, Zhao W 1994 Increased TGF-beta and decreased oncogene expression by omega-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 152:59795987.
  • 24
    Chandrasekar B, Fernandes G 1994 Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by ω-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 200:893898.
  • 25
    Muthukumar AR, Jolly CA, Zaman K, Fernandes G 2000 Calorie restriction decreases proinflammatory cytokines and polymeric Ig receptor expression in the submandibular glands of autoimmune prone (NZB x NZW)F1 mice. J Clin Immunol 20:354361.
  • 26
    Jolly C, Muthukumar A, Reddy Avula C, Troyer D, Fernandes G 2001 Life span is prolonged in food-restricted autoimmune-prone (NZB x NZW)F(1) mice fed a diet enriched with (n-3) fatty acids. J Nutr 131:27532760.
  • 27
    Terada S, Takizawa M, Yamamoto S, Ezaki O, Itakura H, Akagawa KS 2001 Suppressive mechanisms of EPA on human T cell proliferation. Microbiol Immunol 45:473481.
  • 28
    Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, Penninger JM 2000 Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 106:R59R67.
  • 29
    Bligh JA, Dyer WJ 1959 A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911920.
  • 30
    Kates M 1986 Techniques of lipidology: Isolation, analysis and identification of lipids. In: BurdonRH, Van KippenbergPH (eds.) Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 3. Elsevier, New York, NY, USA, pp. 123127.
  • 31
    Griffin MG, Kimble R, Hopfer W, Pacifici R 1993 Dual-energy x-ray absorptiometry of the rat: Accuracy, precision, and measurement of bone loss. J Bone Miner Res 8:795800.
  • 32
    Ammann P, Rizzoli R, Slosman D, Bonjour JP 1992 Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry. J Bone Miner Res 7:311316.
  • 33
    Lu PW, Briody JN, Howman-Giles R, Trube A, Cowell CT 1994 DXA for bone density measurement in small rats weighing 150–250 grams. Bone 15:199202.
  • 34
    Jolly CA, Muthukumar A, Reddy Avula CP, Fernandes G 2001 Maintenance of NF-kappaB activation in T-lymphocytes and a naive T-cell population in autoimmune-prone (NZB/NZW)F(1) mice by feeding a food-restricted diet enriched with n-3 fatty acids. Cell Immunol 213:122133.
  • 35
    Sun D, Muthukumar AR, Lawrence RA, Fernandes G 2001 Effects of calorie restriction on polymicrobial peritonitis induced by cecum ligation and puncture in young C57BL/6 mice. Clin Diagn Lab Immunol 8:10031011.
  • 36
    Kettler DB 2001 Can manipulation of the ratios of essential fatty acids slow the rapid rate of postmenopausal bone loss? Altern Med Rev 6:6177.
  • 37
    Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF 2000 Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130:22742284.
  • 38
    Claassen N, Potgieter HC, Seppa M, Vermaak WJ, Coetzer H, Van Papendorp DH, Kruger MC 1995 Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: Effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone 16:385S392S.
  • 39
    Schlemmer CK, Coetzer H, Claassen N, Kruger MC 1999 Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. Prostaglandins Leukot Essent Fatty Acids 61:381390.
  • 40
    Atkinson TG, Barker HJ, Meckling-Gill KA 1997 Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats. Lipids 32:293302.
  • 41
    Kokkinos PP, Shaye R, Alam BS, Alam SQ 1993 Dietary lipids, prostaglandin E2 levels, and tooth movement in alveolar bone of rats. Calcif Tissue Int 53:333337.
  • 42
    Schlemmer CK, Coetzer H, Claassen N, Kruger MC, Rademeyer C, van Jaarsveld L, Smuts CM 1998 Ectopic calcification of rat aortas and kidneys is reduced with n-3 fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 59:221227.
  • 43
    Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305311.
  • 44
    Pacifici R 1996 Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:10431051.
  • 45
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165176.
  • 46
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315323.
  • 47
    Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345357.
  • 48
    Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304309.
  • 49
    Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT 1999 Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265:144150.
  • 50
    Grcevic D, Lee SK, Marusic A, Lorenzo JA 2000 Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1, 25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. J Immunol 165:42314238.
  • 51
    Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T 2000 T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600605.
  • 52
    Olsen NJ, Kovacs WJ 1996 Gonadal steroids and immunity. Endocr Rev 17:369384.
  • 53
    Bebo BF Jr, Schuster JC, Vandenbark AA, Offner H 1999 Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 162:3540.
  • 54
    Benten WP, Lieberherr M, Giese G, Wunderlich F 1998 Estradiol binding to cell surface raises cytosolic free calcium in T cells. FEBS Lett 422:349353.
  • 55
    Gilmore W, Weiner LP, Correale J 1997 Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 158:446451.
  • 56
    Manolagas SC, Bellido T, Jilka RL 1995 New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: Roles of IL-6 and gp130. Int J Immunopharmacol 17:109116.
  • 57
    Raisz LG 1995 Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 125:2024S2027S.
  • 58
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:35973602.
  • 59
    Horowitz MC 1993 Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260:626627.
  • 60
    Calder PC 2001 Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36:10071024.
  • 61
    Priante G, Bordin L, Musacchio E, Clari G, Baggio B 2002 Fatty acids and cytokine mRNA expression in human osteoblastic cells: A specific effect of arachidonic acid. Clin Sci (Lond) 102:403409.
  • 62
    Calder PC 1996 Immunomodulatory and anti-inflammatory effects of omega-3 polyunsaturated fatty acids. Proc Nutr Soc 55:737774.
  • 63
    Robinson DR, Kremer JM 1991 Rheumatoid arthritis and inflammatory mediators. World Rev Nutr Diet 66:4447.
  • 64
    Kelley VE, Ferretti A, Izui S, Strom TB 1985 A fish oil diet rich in eicosapentanoic acid reduces cyclo-oxygenese metabolites and suppresses lupus in MRL/lpr mice. J Immunol 134:19141919.
  • 65
    Jeng KC, Fernandes G 1991 Effect of fish oil diet on immune response and proteinurea in mice. Proc Natl Sci Counc Repub China B 15:105110.
  • 66
    Fernandes G 1994 Dietary lipids and risk of autoimmune disease. Clin Immunol Immunopathol 72:193197.
  • 67
    Fernandes G 1995 Effect of calorie restriction and omega-3 fatty acids on autoimmunity and aging. Nutr Rev 53:S72S79.
  • 68
    Fernandes G, Chandrasekar B, Luan X, Troyer DA 1996 Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids 31(Suppl):S91S96.
  • 69
    Hamilton LC, Mitchell JA, Tomlinson AM, Warner TD 1999 Synergy between cyclo-oxygenase-2 induction and arachidonic acid supply in vivo: Consequences for nonsteroidal antiinflammatory drug efficacy. FASEB J 13:245251.
  • 70
    Das UN 2002 Estrogen, statins, and polyunsaturated fatty acids: Similarities in their actions and benefits-is there a common link? Nutrition 18:178188.
  • 71
    Das UN 2002 Antiosteoporotic actions of estrogen, statins, and essential fatty acids. Exp Biol Med 227:8893.
  • 72
    Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R 1997 Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:12851289.
  • 73
    Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y 2001 Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 276:563568.
  • 74
    Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y 1998 The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem 273:2835528359.
  • 75
    Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB 1998 Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J Biol Chem 273:2055120555.
  • 76
    Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, Chiarpotto E, Baeuerle PA, Poli G 1996 Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 229:643647.
  • 77
    Erben RG, Raith S, Eberle J, Stangassinger M 1998 Ovariectomy augments B lymphopoiesis and generation of monocyte-macrophage precursors in rat bone marrow. Am J Physiol 274:E476E483.
  • 78
    Masuzawa T, Miyaura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T 1994 Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 94:10901097.
  • 79
    Morony S, Capparelli C, Kostenuik P, Eli A, Scully W, Wiemann B 1999 Osteoprotegerin prevents osteolytic bone destruction in both athymic and syngeneic models of experimental tumor metastasis to bone. J Bone Miner Res 14:S1;1124.
  • 80
    Smithson G, Couse JF, Lubahn DB, Korach KS, Kincade PW 1998 The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol 161:2734.
  • 81
    Ishimi Y, Miyaura C, Ohmura M, Onoe Y, Sato T, Uchiyama Y, Ito M, Wang X, Suda T, Ikegami S 1999 Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140:18931900.
  • 82
    Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M, Suda T 1997 Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: Similarity to estrogen deficiency. Proc Natl Acad Sci USA 94:93609365.
  • 83
    Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T 2000 Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 15:541549.
  • 84
    Manabe N, Kawaguchi H, Chikuda H, Miyaura C, Inada M, Nagai R, Nabeshima Y, Nakamura K, Sinclair AM, Scheuermann RH, Kuro-o M 2001 Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 167:26252631.
  • 85
    Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K, Yamada Y 2000 Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: Implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 15:13211329.